Invention Grant
- Patent Title: Treatment of decreased bone mineral density with zinc and ring finger 3 (ZNRF3) inhibitors
-
Application No.: US16907678Application Date: 2020-06-22
-
Publication No.: US11713461B2Publication Date: 2023-08-01
- Inventor: Da-Wei Gong , Nehal Gosalia , Alan Shuldiner , Cristopher Van Hout , James Perry
- Applicant: Regeneron Pharmaceuticals, Inc. , University of Maryland, Baltimore
- Applicant Address: US NY Tarrytown
- Assignee: Regeneran Pharmaceuticals, Inc.,University of Maryland, Baltimore
- Current Assignee: Regeneran Pharmaceuticals, Inc.,University of Maryland, Baltimore
- Current Assignee Address: US NY Tarrytown; US MD Baltimore
- Agency: Armstrong Teasdale LLP
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61P19/10 ; C12Q1/6874
Abstract:
The present disclosure provides methods of treating patients having decreased bone mineral density, methods of identifying subjects having increased risk of developing decreased bone mineral density, methods of detecting human Zinc And Ring Finger 3 (ZNRF3) variant nucleic acid molecules and variant polypeptides, and ZNRF3 variant nucleic acid molecules and variant polypeptides.
Public/Granted literature
- US20210002647A1 Treatment Of Decreased Bone Mineral Density With Zinc And Ring Finger 3 (ZNRF3) Inhibitors Public/Granted day:2021-01-07
Information query
IPC分类:
